|Bid||131.59 x 200|
|Ask||131.60 x 400|
|Day's Range||131.28 - 132.24|
|52 Week Range||109.32 - 137.08|
|PE Ratio (TTM)||22.07|
|Dividend & Yield||3.36 (2.53%)|
|1y Target Est||N/A|
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals business. Walmsley, who took over in April, said GSK would in future allocate 80 percent of its R&D budget to respiratory and HIV/infectious diseases, along with two other potential areas of oncology and immuno-inflammation.
Starbucks is expected to report earnings of $0.55/share on $5.74 billion in revenue. Meanwhile, the so-called Whisper number is $0.56.
Bullish patterns on the charts of key healthcare-related assets suggest that now could be the time to buy.